Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON (Alliance News) - UK shares have opened higher Friday, as Bank of England Governor Mark Carney backed off of forward guidance and said there is "no immediate need" to raise interest rates.
Royal Mail has reported a 2% increase in like-for-like revenues for th
* Hasegawa wants Weber to come up with ideas in 3-6 months * Major acquisitions not on cards, small bolt-ons possible * Takeda pipeline weakened by diabetes drug setback in Dec By Ben Hirschler DAVOS, Switzerland, Jan 23 (Reuters) - Takeda Pharmaceutical , one of Asia's bi
Read moreGLOBAL MARKETS ROUNDUP * Nifty futures on the Singapore Exchange was down 0.23 percent, while the MSCI-Asia Pacific excluding Japan index gains 0.04 percent. * Asian share markets struggled for inspiration on Wednesday, hampered by expectations of further reductions in the U.S. Federal Reserve'
Read more* Glaxo had sought $571 million, was awarded $3.5 mln * Abbott excluded juror because of sexual orientation * Ruling shows influence of recent Supreme Court opinion By Dan Levine SAN FRANCISCO, Jan 21 (Reuters) - A gay man was improperly excluded from jury service because
Read moreSAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. GSK had won a jury verdict for about $3.5 million again
Read more
- FTSE 100 fails to break 2013 intraday high - Credit squeeze eases in China - IMF lifts global growth forecasts techMARK 2,846.40 -0.25% FTSE 100 6,834.26 -0.04% FTSE 250 16,144.20 -0.51% After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not re
Read moreDrugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. The drug is manufactured by ViiV Healthcare, a company in which GSK, Pfizer and Shionogi are shareholders. Tivicay is for use in combination with other anti-retroviral medicinal
Read moreIntertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong
Read more(An item published at 1259 GMT misstated the market prices. The correct version follows.) LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant Unilever Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and who
Read moreLONDON (Alliance News) - Anglo-Dutch consumer goods and food giant Unilever Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that its joint venture Viiv Healthcare Ltd saw its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission. This regulation authori
Read moreLONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said that Executive Director Moncef Slaoui was allocated 15 American Depositary Shares at a price of USD54.10 each on January 17. Glaxo shares closed at 1,657.68 pence per share Monday, up 0.8%. B
Read moreLONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:
----------
FTSE 100
----------
CREDIT SUISSE RAISES NEXT PRICE TARGET TO 6500 (5500) PENCE - 'NEUTRAL'
----------
BERENBERG RAI
Credit Suisse predicts major European drugmakers will report 4 percent sales growth and 6 percent earnings per shares (EPS) growth this year, with companies such as Bayer and Novartis seen outperforming the market. It expects that Roche will also do well. "EU Pharma benefitted from a
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC Friday said Deidre Connelly, divisional president and Bill Louv, divisional senior vice president bought American Depositary shares following the re-investment of dividends January 9.
Details are as follows.
Last checked at